OBJECTIVE: To investigate the mechanisms of spinal cord repair and their relative contribution to clinical recovery in patients with multiple sclerosis (MS) after a cervical cord relapse, using spinal cord (1)H-magnetic resonance spectroscopy (MRS) and volumetric imaging. METHODS: Fourteen patients with MS and 13 controls underwent spinal cord imaging at baseline and at 1, 3, and 6 months. N-acetyl-aspartate (NAA) concentration, which reflects axonal count and metabolism in mitochondria, and the cord cross-sectional area, which indicates axonal count, were measured in the affected cervical region. Mixed effect linear regression models investigated the temporal evolution of these measures and their association with clinical changes. Ordinal logistic regressions identified predictors of recovery. RESULTS: Patients who recovered showed a sustained increase in NAA after 1 month. In the whole patient group, a greater increase of NAA after 1 month was associated with greater recovery. Patients showed a significant decline in cord area during follow-up, which did not correlate with clinical changes. A worse recovery was predicted by a longer disease duration at study entry. CONCLUSIONS: The partial recovery of N-acetyl-aspartate levels after the acute event, which is concurrent with a decline in cord cross-sectional area, may be driven by increased axonal mitochondrial metabolism. This possible repair mechanism is associated with clinical recovery, and is less efficient in patients with longer disease duration. These insights into the mechanisms of spinal cord repair highlight the need to extend spinal cord magnetic resonance spectroscopy to other spinal cord disorders, and explore therapies that enhance recovery by modulating mitochondrial activity.
OBJECTIVE: To investigate the mechanisms of spinal cord repair and their relative contribution to clinical recovery in patients with multiple sclerosis (MS) after a cervical cord relapse, using spinal cord (1)H-magnetic resonance spectroscopy (MRS) and volumetric imaging. METHODS: Fourteen patients with MS and 13 controls underwent spinal cord imaging at baseline and at 1, 3, and 6 months. N-acetyl-aspartate (NAA) concentration, which reflects axonal count and metabolism in mitochondria, and the cord cross-sectional area, which indicates axonal count, were measured in the affected cervical region. Mixed effect linear regression models investigated the temporal evolution of these measures and their association with clinical changes. Ordinal logistic regressions identified predictors of recovery. RESULTS:Patients who recovered showed a sustained increase in NAA after 1 month. In the whole patient group, a greater increase of NAA after 1 month was associated with greater recovery. Patients showed a significant decline in cord area during follow-up, which did not correlate with clinical changes. A worse recovery was predicted by a longer disease duration at study entry. CONCLUSIONS: The partial recovery of N-acetyl-aspartate levels after the acute event, which is concurrent with a decline in cord cross-sectional area, may be driven by increased axonal mitochondrial metabolism. This possible repair mechanism is associated with clinical recovery, and is less efficient in patients with longer disease duration. These insights into the mechanisms of spinal cord repair highlight the need to extend spinal cord magnetic resonance spectroscopy to other spinal cord disorders, and explore therapies that enhance recovery by modulating mitochondrial activity.
Authors: S Narayanan; N De Stefano; G S Francis; R Arnaoutelis; Z Caramanos; D L Collins; D Pelletier; J P Antel; D L Arnold Journal: J Neurol Date: 2001-11 Impact factor: 4.849
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Simon J Hickman; Ahmed T Toosy; Stephen J Jones; Daniel R Altmann; Katharine A Miszkiel; David G MacManus; Gareth J Barker; Gordon T Plant; Alan J Thompson; David H Miller Journal: Brain Date: 2004-09-01 Impact factor: 13.501
Authors: Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser Journal: J Cereb Blood Flow Metab Date: 2012-01-04 Impact factor: 6.200
Authors: O T Wiebenga; A M Klauser; M M Schoonheim; G J A Nagtegaal; M D Steenwijk; J A van Rossum; C H Polman; F Barkhof; P J W Pouwels; J J G Geurts Journal: AJNR Am J Neuroradiol Date: 2015-03-05 Impact factor: 3.825
Authors: Khaled Abdel-Aziz; Torben Schneider; Bhavana S Solanky; Marios C Yiannakas; Dan R Altmann; Claudia A M Wheeler-Kingshott; Amy L Peters; Brian L Day; Alan J Thompson; Olga Ciccarelli Journal: Brain Date: 2015-04-10 Impact factor: 13.501
Authors: Allan R Martin; Izabela Aleksanderek; Julien Cohen-Adad; Zenovia Tarmohamed; Lindsay Tetreault; Nathaniel Smith; David W Cadotte; Adrian Crawley; Howard Ginsberg; David J Mikulis; Michael G Fehlings Journal: Neuroimage Clin Date: 2015-12-04 Impact factor: 4.881
Authors: C A Wheeler-Kingshott; P W Stroman; J M Schwab; M Bacon; R Bosma; J Brooks; D W Cadotte; T Carlstedt; O Ciccarelli; J Cohen-Adad; A Curt; N Evangelou; M G Fehlings; M Filippi; B J Kelley; S Kollias; A Mackay; C A Porro; S Smith; S M Strittmatter; P Summers; A J Thompson; I Tracey Journal: Neuroimage Date: 2013-07-14 Impact factor: 6.556
Authors: Patrick Freund; Claudia Wheeler-Kingshott; Jonathan Jackson; David Miller; Alan Thompson; Olga Ciccarelli Journal: Mult Scler Date: 2010-08-04 Impact factor: 6.312